Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hundreds of dietary supplements have been reported to improve cognitive and emotional function in humans, but few have scientific foundation. A new study from the Department of Physiology, Anatomy & Genetics (DPAG) provides fresh insight into how dietary magnesium supplementation can influence memory performance.

Fluorescent close up of the fly brain showing that a key magnesium transporter dominates the neurons involved in memory.
The fly CNNM protein (green, shown to cover the entire area) is abundant in memory-relevant neurons in the fly brain

Prior research has shown that supplementing the diet of young and aging rodents with Magnesium improves their memory and it even appears to partially restore memory deficits in animals harbouring models of Alzheimer’s disease. Magnesium may therefore have therapeutic potential for humans with memory issues.

Yanying Wu, a Postdoctoral Fellow in DPAG's Waddell group, first showed that Magnesium feeding also improved memory of fruit flies (Drosophila). According to Professor Scott Waddell: “We reasoned that if Magnesium enhanced fly memory, this would indicate that it is a general feature of memory systems, and would allow us to analyse the underlying biology." Importantly, the memory-enhancing effects of Magnesium appear to involve a different mechanism to that previously proposed in rodents. The Waddell group found that a conserved Magnesium transporter (known as a Cyclin M2 or CNNM protein) was essential for normal and Magnesium-enhanced memory. Magnesium feeding increased the levels of Magnesium in memory-relevant neurons and the CNNM transporter is critical to regulate these elevated levels.

The full story is available on the Department of Physiology, Anatomy & Genetics website

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.